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“No monitoring device, no matter how accurate or complete, would be expected 
to improve patient outcome, unless coupled to a treatment that itself improves 
outcome” 
 
Michael R Pinsky 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABSTRACT 
Effective pulmonary blood flow (EPBF) i.e. cardiac output (CO) minus shunt flow could be 
estimated by a capnodynamic equation. Via introduction of short pauses in the ventilatory 
pattern the required alterations of carbon dioxide are induced. By integrating the alterations 
into the equation EPBF could be calculated. The mathematical formula also includes an 
equation term, effective lung volume (ELV) that has previously been shown to correlate to 
FRC.  
The capnodynamic method (COEPBF) was evaluated during haemodynamic and ventilatory 
alterations in a porcine model before and after lung lavage. An ultrasonic flow probe 
positioned around the pulmonary trunc (COTS) was used as a reference method for CO. ELV 
was compared to the sulphur hexafluoride (SF6) method and stability during CO alterations 
was assessed. Two different ventilation patterns were studied, in papers I-III a pattern based 
on inspiratory holds and in paper IV a pattern based on expiratory holds. Bland Altman 
statistics were used for evaluation of the agreement for absolute values and the four-quadrant 
and polar plot methodologies were used to assess trending ability. 
COEPBF based on inspiratory holds showed good agreement and trending abilities at PEEP 5 
cmH2O. However, a paradoxical increase was seen when PEEP was increased to 12 cmH2O.  
Lung lavage resulted in a significant decrease in lung function with a two-fold increase in 
shunt fraction and the performance of COEPBF was significantly impaired. However, the 
trending ability was largely preserved when assessed by the four-quadrant methodology. 
The shunt fraction was dependent of CO regardless of the degree of lung injury and PEEP 
level. When shunt levels were > 20%, COEPBF underestimated COTS.  
ELV was not significantly affected by CO alterations at an unchanged PEEP level. A small 
difference between ELV and FRCPEEP was seen at PEEP 5 cmH2O before lavage and at PEEP 
12 cmH2O after lavage. 
Since a ventilatory pattern based on inspiratory holds is likely to affect the pulmonary 
capillary blood flow per se a modification of the pattern might improve the performance.  A 
ventilatory pattern based on expiratory holds could be assumed to reduce this variation. In 
paper IV, when COEPBF was based on expiratory holds, this paradoxical increase in COEPBF 
was not displayed and the performance was improved. 
This capnodynamic method could be considered a non-invasive alternative for estimation of 
EPBF and ELV in mechanically ventilated subjects without significant lung pathology. 
Considering that the ability to detect trends is good, this device might have the prerequisite to 
be used to guide goal-directed treatment protocols for CO optimisation.  
 
Keywords; cardiac output, pulmonary blood flow, lung lavage, shunt flow, carbon dioxide, 
alveolar, hemodynamic, porcine model, sulphur hexafluoride, pulmonary trunc, mechanical 
ventilation, goal directed therapy 
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INTRODUCTION 
 
PROLOGUE 
Once upon a time in a fairly large town a young and enthusiastic doctor started working in a 
hospital. From dusk till dawn and sometimes even during the night she tended to patients in 
the operating theatres and pondered the variations of the numbers displayed on the patient 
monitors. She asked the older doctors about those numbers and what they really meant. 
Although they discussed these variations and possible treatments she did not really 
understand as much as she wished. She went home to her house and read the old book she 
used to study in school. Despite her best efforts it was not possible to find an answer and the 
older doctors could not help her anymore.  
The young doctor often reflected upon something frightening. Some of the patients she tried 
her best to look after in the operating theatre became ill and sometimes they died before 
leaving the hospital. She wondered, “Could I do something better to prevent this?” 
Sometimes the other doctors and nurses told her that she pondered too much for her own 
good.  
The still young but now a bit more experienced doctor was curious and started to search for 
guidance from other sources. She was now really frustrated because she realised that she had 
to learn more to be able to even understand what the numbers really meant. To acquire that 
knowledge the fairly young doctor moved to the large hospital in town.   
The doctors and nurses at the large hospital welcomed her. They seemed to like her 
pondering although the numbers on the patient monitors varied as much here as at her last 
hospital. The now a bit more experienced doctor realised that all questions don’t have 
answers, but with the right skills, hard work and funding from the king himself she might be 
able to contribute some answers on her own.  
The not really young doctor began her journey as a researcher gaining the skills to understand 
other sources, doing experiments, writing science, and counting statistics: in the end hoping 
to contribute with new knowledge into the world. You could say that research resembles the 
fairy tale of frogs, kisses and finding the prince. A lot of hypotheses have to be formulated 
and tested before you have the result you desire. 
Finally, the former young doctor who was convinced that she preferred to work as a clinician 
realised that research is a prerequisite for improving care for patients. 
 
So, this is not the end of the story, this is just the beginning of a new fairy tale. 
 
Enjoy! 
 
Caroline Hällsjö Sander  
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CARDIAC OUTPUT AND CIRCULATION 
1628 William Harvey described his discovery of the circulation of blood (1) “Exercitatio 
Anatomica de Motu Cordis et Sanguinis in Animalibus” which translates to ”An 
Anatomical Exercise on the Motion of the Heart and Blood in Living Beings”. Since then 
the function of the heart and circulatory system have been further assessed and described in 
detail. Several methods for cardiac output (CO) monitoring have been developed and are 
used in haemodynamically unstable patients in intensive care units and operating theatres. 
This subject is of great interest for perioperative and intensive care physicians resulting in 
numerous studies describing the advantages and disadvantages of new and established CO 
monitors (2, 3). Cardiac output monitoring has also been assessed in combination with 
predefined goal directed protocols. Several studies display a decreased morbidity rate and 
sometimes even decreased mortality when CO monitoring was used to guide CO optimisation 
(4-6). 
 
CARDIAC OUTPUT MONITORING IN THE PERIOPERATIVE SETTING 
Approximately 230 million patients undergo surgery world wide every year (7). In Europe 
and the United States > 10% of patients undergoing surgical procedures run an increased risk 
of major complications. Approximately up to 5% die before being discharged from the 
hospital (8-11). This group of patients is defined as a high-risk population for perioperative 
complications and accounts for 80% of postoperative deaths (12). Preventing postoperative 
complications is crucial in order to reduce morbidity and mortality and is also cost-effective 
(13). 
High-risk surgical patients seem to have less capacity to adjust to the increased demand of 
oxygen delivery associated with surgical trauma in the perioperative period (12, 14). 
Unfortunately, standard peroperative monitoring is limited to basic haemodynamic 
parameters including heart rate, blood pressure and saturation, which have been shown to 
correlate poorly to flow-based vital parameters and oxygen delivery (15). In contrast CO is 
closely associated with oxygen delivery and tissue perfusion (16, 17).  
In perioperative high-risk surgical patients CO monitoring is essential to guide fluid, 
vasopressor and inotropic therapy to optimise oxygen delivery. In this population CO 
monitoring and subsequent optimisation with goal directed therapy (GDT) protocols has been 
shown to reduce the risk of postoperative complications. Despite this, CO monitoring is not 
widely used in the perioperative setting (18-21).  
Intubation and mechanical ventilation is commonly required during general anaesthesia.  
Suboptimal ventilator settings might negatively affect both ventilation and perfusion of the 
lung and could be potentially harmful (22). Standard monitoring in ventilated patients 
assesses pulmonary pressures and volumes without taking the pulmonary circulation into 
account. A method integrating monitoring of both pressures and perfusion in the lung could 
be an attractive tool for optimisation of ventilator settings.  
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CARDIAC OUTPUT MONITORING  
Thermodilution  
The pulmonary artery catheter (PAC) (Edwards Lifesciences, Irvine, CA, USA) is 
considered to be the clinical reference method for CO monitoring. The device can be 
calibrated manually by injection of a known volume with a known temperature into the right 
atrium via the proximal injection port. The injected volume is carried by the circulation and 
diluted (23). A thermistor placed downstream in the circulation senses the change in 
temperature and CO can be calculated. The inherent precision of the method is improved if 
three bolus injections are performed and an average of these are used for calculation of CO 
(24). Commonly an automated mode induces intermittent heating of an electric filament 
attached to the PAC approximately 15 to 25 cm proximal from its tip for continuous CO 
monitoring. The subsequent series of heat signals from the thermistor on the tip are used to 
generate a thermodilution curve (23). 
Limitations include the complications described in the literature associated with invasiveness 
(25). The system requires a specially designed catheter inserted via a central vein guided by 
pressure signals through the right ventricle into the pulmonary artery. Insertion of the device 
and interpretation of the data requires a trained operator (23, 25).  
Besides being considered the clinical reference method for CO monitoring advantages 
include the opportunity for additive information, such as estimation of pulmonary vascular 
pressures and mixed venous gas saturation (23). Patient outcome data when the PAC was 
used to guide CO optimisation are not uniform and the use of the device is declining. 
However, some authors argue for an increased use in selected patients groups, for example 
patients with a severely impaired cardiac function due to an acute illness (25-27).  
Ultrasound and Doppler techniques 
The oesophageal Doppler measures blood flow velocity in the descending thoracic aorta by 
means of a Doppler transducer placed at the tip of a single-use probe. The probe is inserted 
via the oesophagus until a characteristic aortic velocity signal is found. According to the 
pulse wave Doppler principle the distance the blood travels during systole equals the velocity 
time integral (VTI). Stroke volume (SV) and CO are calculated from an average of usually 
five VTI values and the cross sectional area of the aorta. The CardioQ device (Deltex 
Medical, Chichester, West Sussex, UK) uses a validated population-based internal chart for 
estimation of the cross sectional area of the aorta in correlation to the sex, weight, height 
and age of the patient (28).  
Limitations are the necessity for manual manipulation of the probe position since a 
suboptimal angle of insonation decreases the accuracy of the method. A poor signal is often 
associated with an underestimation of CO. A reoccurring problem in the operating room is 
interference with the Doppler signal from the electric cautery. The position of the probe only 
permits measurements of blood flow to the lower parts of the body. This has been accounted 
for in the algorithm assuming the distribution to be 70% of CO to the lower parts of the body. 
A potential source of error is if this relation is altered (28-30). Pathology in the oesophagus is 
a contraindication for inserting a probe.  
Caroline Hällsjö Sander  
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Several studies have shown a positive impact on outcome with a reduced length of stay in 
the high-risk surgical population (29-34) and the method is recommended by the National 
Institute for Health and Care Exchange (NICE) for use in patients undergoing high-risk 
surgery or other surgical patients in whom the clinician would consider using invasive CO 
monitoring. However, the positive effect on outcome has been questioned in more recent 
studies (35).   
The Ultrasonic Cardiac Output Monitor (USCOM, Sydney, Australia) is a non-invasive 
ultrasound probe measuring CO at the sternal notch (trans aortic blood flow) or at the left 
parasternal position (transpulmonary blood flow). The area of the outflow tract is estimated 
by a nomogram based on the subject’s height. Stroke volume is calculated as a product of 
VTI and the estimated cross sectional area (2, 28). 
Potential limitations and sources of error are associated with estimation of the outflow tract 
area by a chart or obtaining a suboptimal flow signal. Both the operator and the subject could 
trigger this suboptimal result. An advantage of this method its total non-invasiveness. The 
accuracy of the method when compared to thermodilution varies between high and poor (36, 
37).  
Echocardiography 
Measurements can be obtained by a transoesophageal or a transthoracic view and SV can be 
measured in two different ways. The volumetric approach by estimating the end-systolic and 
end-diastolic left ventricular volume and subtracting one from the other or by applying the 
Doppler technique multiplying VTI with the cross sectional area of the left ventricular 
outflow tract (2, 3). This technique has been described as an ideal CO monitor because of 
precise estimation of CO in combination with the ability to estimate other aspects of cardiac 
performance like ventricular and valvular function (3). However, like the other 
ultrasound/Doppler methods it is unsuitable for continuous CO monitoring. The high costs 
associated with the equipment and the considerable need for education limits the use of 
echocardiography (3). 
Thoracic bioimpedance and bioreactance 
Cardiac output is calculated through analysis of variation in voltage in response to a high 
frequency transthoracic current (3). Several studies comparing bioimpedance with 
thermodilution show poor agreement (38-40). In a later study with updated versions of the 
method the results improved (41). However, there seems to be several limitations with this 
technique. Decreased accuracy is associated with volume overload and increased amount of 
extravascular lung-water, variations of patient size, temperature, humidity and the positioning 
of the electrodes (2).  
Bioreactance technology processes the impedance signal in a different way by measuring the 
phase shift in voltage across the thorax. When compared to thermodilution and pulse contour 
analysis the results are promising (42-44). Both methods are entirely non-invasive.  
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Pulse contour analysis 
Arterial waveform analysis is based on the relation between blood pressure, SV, arterial 
compliance, and systemic vascular resistance (SVR) (45). The major limitations are 
haemodynamic instability, cardiac arrhythmias and other factors disturbing the arterial 
waveform such as changes in the vascular resistance (45).  
Calibrated pulse contour analysis 
Two methods based on pulse contour analysis in combination with transpulmonary 
thermodilution with saline for calibration are available; PiCCO (Pulsion, Munich, Germany) 
and the more recently introduced Volume view/EV1000 (Edwards Lifesciences, Irvine, CA, 
USA). Transpulmonary thermodilution have been shown to be a reliable alternative to the 
PAC, however, the methodology is invasive and requires a central arterial and venous line 
(23).   
The PiCCO methodology is based on the principle that SV is proportional to arterial pulse 
pressure and inversely proportional to arterial compliance. Cardiac output is calculated by 
dividing the area under the systolic part of the arterial curve by the aortic compliance. 
During calibration with transpulmonary thermodilution the aortic compliance and resistance 
are estimated and updated. Between calibrations those values are reassessed by an 
algorithm based on the arterial pressure curve (46). The transpulmonary thermodilution 
technology provides the clinician with additional values, for example extra-vascular lung 
water and global end-diastolic volume (47) 
Clinical limitations includes a need for frequent calibrations especially when the arterial 
resistance changes and the requisite for a central arterial and venous line (46).  
A pulse contour analysis combined with lithium chloride transpulmonary dilution for 
calibration (LiDCOgroup, Cambridge, UK) is less invasive than devices calibrated with 
saline considering the technology only requires a peripheral arterial and venous line.  
The performance of this pulse contour analysis is comparable with other pulse contour 
techniques (2, 48) and the results are equivalent when the lithium indicator dilution technique 
is compared to thermodilution (49). 
The limitations include requirement for recalibration after haemodynamic changes (2). 
Furthermore, muscle relaxants (vecuronium and pancuronium) interact with lithium chloride 
and decreases the accuracy of calibration after muscle relaxant has been administered. 
Patients treated with lithium or pregnant women in the first trimester should not be monitored 
with LiDCOplus. Additionally, injection of lithium chloride in not authorised in all countries 
(46, 50). 
Non-calibrated monitors 
The basic principle of FloTrac/Vigileo (Edwards Lifesciences, Irvine, CA) is the linear 
relationship between pulse pressure and SV. Arterial compliance and resistance is estimated 
from a validated nomogram and morphological patient data; sex, age, height and weight that 
has to be programmed into the system (45, 46).  Data points are collected from the arterial 
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waveform and pulse pressure is calculated from the standard deviation of those (45). The 
system is operator independent and requires only a peripheral arterial line connected to the 
special pressure transducer. The most recent software showed improved performance 
especially in normal- and hypodynamic states with a decreased percentage error (PE) 
compared to earlier versions. However, in hyperdynamic states and during infusion of 
vasopressors the system performed poorly (51, 52).  
The ProAQT/Pulsioflex (Pulsion, Munich, Germany) is a recently introduced device similar 
to the FloTrac but the software for pressure waveform analysis is different and a new 
algorithm providing an auto-calibration calculates the initial CO value. It is possible to reset 
this value by calibration manoeuvres and add a value obtained by another CO monitor (46, 
52). This device was recently introduced so the numbers of studies are limited. However, 
the main findings display ability to track changes comparable to FloTrac but a poor 
agreement for absolute values. The auto-calibration did not improve the performance. (52).  
LiDCOrapid (LiDCOgroup Cambridge, UK) uses the same algorithm as the LiDCOplus but 
a nomogram assesses the aortic compliance abolishing the need for calibration. The method 
has similar limitations as the other non-calibrated CO methods with decreased reliability 
when the vascular tone changes rapidly (53). 
The pressure recording analytical method (PRAM) (Mostcare; Vytech Health, Padova, 
Italy) calculates CO based on the area under the arterial pressure curve, the analytical 
description of the arterial pressure waveform and the instantaneous acceleration of the 
arterial vessel cross-sectional area. This device does not require patient data or calibration 
and is semicontinuous (53). The reliability for absolute values is low (53). 
The Nexfin (Edwards Lifesciences, Irvine, CA, USA) provides continuous values obtained 
by an inflatable finger cuff. Stroke volume is calculated by dividing the pulsatile systolic 
area of each beat by the computed aortic compliance. Gender, age, height and weight are 
programmed into the system and the algorithm is developed on the basis of a large human 
database including non-invasive and invasive arterial pressure tracings together with 
thermodilution. The performance was found to be accurate when used in intraoperative 
patients but declines in septic haemodynamic unstable patients in the intensive care unit (3). 
 
CALCULATION OF CARDIAC OUTPUT BY FICK’S EQUATION 
Fick’s equation 
Adolf Fick published an article in 1870 describing how CO could be calculated by integrating 
the oxygen or carbon dioxide content from a sample of pulmonary arterial and systemic 
arterial blood into an equation (54) (Figure 1). 
Fick’s principle was validated in humans in 1930 when researchers obtained samples of a 
mixed venous gas from brave volunteers by puncturing the right ventricle with a spinal tap 
needle via the thoracic wall (55) (Figure 2). 
Introduction 
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The introduction of heart catheterisation in 1940 permitted access to the pulmonary artery and 
Fick’s principle became a clinically applicable method in humans (56). Estimation of 
pulmonary blood flow from the uptake of oxygen or elimination of carbon dioxide is the 
oldest known methodology for calculation of CO. 
  
 
Figure 1. Painting of Adolf Fick (1829-1901). 
 
 
                     𝐶𝑂 = !"#!!"!#!!!"!#! 
 
Figure 2. Fick’s classical equation states that the amount of carbon dioxide eliminated by the lungs equals the 
amount being transferred to the lungs by the blood during steady state conditions. CO expresses the pulmonary 
blood flow, VCO2 equals the elimination of carbon dioxide by the lungs, CVCO2 the mixed venous content of 
carbon dioxide and CaCO2 the systemic arterial carbon dioxide content. 
Indirect Fick’s method 
In contrast to the invasive sampling of mixed venous and arterial blood gases, analyses of 
expired gases is non-invasive and can be accomplished continuously. Analysis of expired 
carbon dioxide could be used for calculation of pulmonary blood flow by an indirect Fick’s 
principle. This approach is dependent on induced alterations of the alveolar concentration of 
Caroline Hällsjö Sander  
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carbon dioxide and allows semicontinuous calculations of effective pulmonary blood flow 
(EPBF) i.e. CO minus intrapulmonary shunt (57-59).  
Three main principles have been described for induction of the required alterations of carbon 
dioxide; 1) change of alveolar ventilation 2) alter dead space and 3) add carbon dioxide to the 
inspiratory gas (57, 59).  
When the carbon dioxide concentration is altered in a predefined way the equation could be 
further developed and rewritten describing two different levels of ventilation, before (b) and 
after (a) a change of ventilation was induced. 
 
Equation 1                       𝑽𝑪𝑶𝟐 𝒃 = 𝑬𝑷𝑩𝑭 ∙ (𝑪𝒗𝑪𝑶𝟐 − 𝑪𝒄𝑪𝑶𝟐 𝒃 ) 
Equation 2                        𝑽𝑪𝑶𝟐 𝒂 = 𝑬𝑷𝑩𝑭 ∙ (𝑪𝒗𝑪𝑶𝟐 − 𝑪𝒄𝑪𝑶𝟐 𝒂 ) 
 
Equation 1 describes the mathematical association between the measured elimination of 
carbon dioxide (VCO2) [L/min] and EPBF [L/min] multiplied with the difference between 
the mixed venous concentration of carbon dioxide (CvCO2) [Lgas/Lblood] and concentration 
of carbon dioxide in the pulmonary end-capillary arteries (CcCO2) [Lgas/Lblood]. Equation 2 
describes the same relation after an alteration of ventilation has been induced.  
If the mixed venous carbon dioxide concentration is assumed to be constant when 
measurements are obtained the equation could be further developed.  
 
 𝑬𝑷𝑩𝑭 = (𝑽𝑪𝑶𝟐 𝒃 − 𝑽𝑪𝑶𝟐 𝒂 )𝑺𝑪𝑶𝟐 ∙ (𝒑𝑨𝑪𝑶𝟐 𝒂 − 𝒑𝑨𝑪𝑶𝟐 𝒃 ) 
 
This allows calculation of EPBF from quantities measureable in the expired gas. The 
coefficient of solubility for carbon dioxide in blood SCO2 [Lgas/Lblood/mmHg] is integrated 
into the equation to convert the alveolar partial pressure [mmHg] to concentration of carbon 
dioxide [Lgas/Lblood]. The partial pressure of carbon dioxide in the pulmonary end-capillary 
arteries is estimated from the measured alveolar concentration of carbon dioxide. 
Via the development of modern ventilators with software control this old Fick’s principle, 
when modified, could offer an alternative for estimation of EPBF. This approach could be 
considered non-invasive in the large group of patients requiring intubation and mechanical 
ventilation during general anaesthesia (7, 60, 61).  
Changing alveolar ventilation  
In 1980 Gedeon et al. described an indirect Fick method for bedside determination of EPBF 
in intubated and mechanically ventilated subjects. The method was evaluated in anaesthetised 
dogs during baseline (BL) conditions and subsequent controlled bleeding and in patients 
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anaesthetised for cardiac surgery. The results in dogs when compared to thermodilution were 
encouraging. However, the results in patients were not stated in the article (62).  
The basic idea described was to induce intermittent cyclic changes in the alveolar 
concentration of carbon dioxide while the mixed venous concentration of carbon dioxide 
remained constant. A variable pause, a short breath hold between inspiration and expiration, 
generated periods of hypo- and hyperventilation leading to changes in minute ventilation and 
subsequent rapid changes in alveolar end-tidal partial pressures of carbon dioxide (pACO2ET) 
and VCO2. With this approach the tidal volume, inspiratory and expiratory time remained 
constant, a precondition for minimal perturbation of the pulmonary blood flow per se. The 
method required 15 minutes of recovery between measurements to secure steady state 
conditions. Keeping the expiratory time constant allowed pACO2ET to be recorded at 
comparable points of the alveolar plateau (62). 
This was followed by a publication in 2002 when a modified mathematical formula and 
breathing pattern was evaluated. In the previous settings the required perturbation of gas 
exchange was maintained for typically 15-30 seconds. An alternative approach based on a 
cyclic reoccurring single short breath hold was likely to induce fewer disturbances to the 
physiology. Including 1-3 subsequent normal breaths, until pACO2ET is re-established, could 
be an attractive alternative to longer lasting perturbations. The benefit from including the 
information from the recovery phase was studied in patients anaesthetised for cardiac surgery 
(60).  
In order to separate the gas exchange between the pulmonary blood and the alveoli from 
effects due to changes in the carbon dioxide stores in the lung tissue a formula for calculating 
the effective lung volume (ELV) was introduced into the equation. In this study it was 
suggested that ELV corresponds to the volume in the alveoli where carbon dioxide is 
distributed. 
Adding dead space 
In 1988 Capek et al. described a semicontinuous approach for calculation of CO by variation 
of dead space. This method was evaluated during alterations of CO and after induction of 
pulmonary oedema in dogs. A key finding was that pACO2ET increased exponentially 
although the concentration of carbon dioxide in mixed venous blood remained stable during 
partial rebreathing. The agreement was acceptable when compared to thermodilution. 
Normal ventilation was followed by 30 seconds of partial rebreathing providing EPBF values 
every 3.5 minutes and pACO2ET was used as a substitute for pulmonary end-capillary 
concentration of carbon dioxide although corrected for dead space. In this mathematical 
approach the effect of the haemoglobin level of the dissociation curve for carbon dioxide was 
added into the equation (63). 
In 1995 Gedeon’s mathematical formula was evaluated by intermittent increase of dead 
space. This approach was evaluated both in intubated patients and after extubation. The post 
mechanical ventilation measurements were obtained through a mouthpiece. In contrast to the 
high performance during mechanical ventilation the measurements during spontaneously 
breathing showed less reliability due to technical problems (64).  
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Adding dead space in the clinical setting 
The non-invasive cardiac output monitor (NICO Respironics, Murrysville, PA) is designed 
for use in mechanically ventilated patients. It requires integration of a specially designed 
circuit for automated partial rebreathing between the endotracheal tube and the Y-piece. 
Varying serial dead space through cyclic reoccurring opening and closing of the valve to 
the extra circuit induces the required alterations of pACO2ET and VCO2. A recording cycle 
lasts for approximately three minutes inducing semicontinuous measurements. The period 
of rebreathing lasts for 50 seconds in the former version of software but has been shortened 
to 30 seconds in the latest version (5.0) (65). Most studies have been performed with the 
former version (Figure 3). 
 
 
 
Figure 3. The NICO loop and valve for rebreathing connected between the Y-piece and the endotracheal tube 
in the animal laboratory setting. 
 
Effective pulmonary blood flow is calculated by integrating the difference in VCO2 and 
pACO2 between the rebreathing and non-rebreathing periods. The shunt fraction is 
calculated by incorporating estimated values of paO2 derived from pulsoximetry and the 
inspired fraction of oxygen (FiO2) into Nunn’s iso-shunt fraction plots (57). Cardiac output 
is obtained by adding the estimated shunt fraction to EPBF. There is an option to manually 
enter BL parameters, for example FiO2 and paO2. This may contribute to an improved 
agreement when high FiO2 fractions are used (66).  
The performance of the method has been compared to thermodilution in several animal and 
human studies. The results diverge from good to acceptable to poor agreement (59, 66-69).  
Lung injury with subsequent disturbances in the ventilation and perfusion ratio has been 
shown to negatively affect the performance of the method (67, 68). However, it should be 
noted that the majority of studies evaluate the NICO with the former version of software. A 
more recent study with updated software (5.0) found that the negative side effects of partial 
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rebreathing were reduced with preserved performance comparable with continuous CO 
measured by the PAC (69). 
A capnodynamic equation for calculation of ELV and COEPBF 
In 2013 Albu et al. described a novel mathematical approach to a capnodynamic equation for 
calculation of ELV (70). When evaluated in intubated and ventilated subjects the results were 
promising showing a high correlation between ELV and the reference method. The equation 
also includes a factor representing EPBF that was not evaluated per se in the study. 
Without changing the tidal volume, alveolar ventilation was varied via multiple cyclic 
reoccurring short inspiratory pauses that resulted in alterations of the alveolar fraction of 
carbon dioxide (FACO2) and elimination (VTCO2) between breaths. These variations were 
integrated into the equation described below and the three unknown variables; ELV, EPBF 
and CVCO2 could be calculated.  
 
 
 
The induced fluctuations in the alveolar concentration of carbon dioxide were approximately 
4-8 mmHg. The equation compares the carbon dioxide content and the corresponding 
elimination induced by short periods of altered ventilation. After the prolonged breaths the 
ventilation frequency is slightly increased. This counteracts alterations of FACO2 and 
abolishes the need for a period of equilibration. Therefore, the mixed venous content of 
carbon dioxide could be assumed to be constant and the breathing pattern and capnodynamic 
calculations could be performed continuously. In 2006 Peyton et al. suggested a similar 
approach for a semicontinuous capnodynamic method based on variations of the tidal volume 
(71). 
In summary 
Numerous studies evaluating cardiac output monitors per se or combined with a goal directed 
protocol for haemodynamic optimisation in relation to patient outcome have been published 
(2, 5, 17, 72, 73). Each monitor is associated with both advantages and disadvantages 
varying with the study population and haemodynamic conditions (3).  
This thesis describes the first studies of a capnodynamic method in an animal model 
including significant haemodynamic and ventilatory challenges not possible to study in 
humans.  
As clinicians we are exposed to new equipment not always properly evaluated but 
nevertheless introduced into the clinic (74). Our aim has been to stepwise challenge the 
method in extreme conditions to expose flaws and scrutinise the model. To accomplish this 
we have used a precise reference method considered to be the gold standard for CO 
monitoring in animal research (75, 76) and modern updated statistical methods including the 
( ) ( )12 2 2 2 2n n n n nA A v cELV F CO F CO EPBF t C CO C CO VTCO−⋅ − = ⋅Δ ⋅ − −
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polar plot methodology (77). It has also been our intention to contribute with our medical 
expertise to further refinement and improvement of the method.  
Maquet Critical Care AB, Solna, Sweden, developed the technical solution of the 
capnodynamic method evaluated it this thesis. 
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AIMS 
 
 
The overall objective of this thesis was to evaluate a novel capnodynamic method for 
estimation of EPBF and ELV in a porcine model.  
 
To validate COEPBF as assessed by a capnodynamic method based on inspiratory holds, 
against an ultrasonic reference method and COPAC during haemodynamic alterations.  
 
To validate COEPBF as assessed by a capnodynamic method based on inspiratory holds 
against an ultrasonic reference method during haemodynamic and ventilatory alterations 
before and after lavaged-induced lung injury. 
 
To evaluate the equation term, ELV, as assessed by a capnodynamic method based on 
inspiratory holds during CO alterations and the agreement and precision when compared to a 
reference method for FRCPEEP during ventilatory alterations before and after lavaged-induced 
lung injury. 
 
To validate COEPBF as assessed by a capnodynamic method based on expiratory holds against 
an ultrasonic reference method during haemodynamic and ventilatory alterations. 
 
 
 
 
 
 
 
 
 
 
 
Caroline Hällsjö Sander  
 14 
 
Materials and Methods 
   15 
MATERIALS AND METHODS 
 
Detailed methodological descriptions are given in each paper. General aspects are presented 
in the section below. 
 
ETHICAL CONSIDERATIONS 
The Animal Research Ethics Committee of Uppsala University approved of all experiments. 
The studies were performed at Hedenstierna Laboratory at Uppsala Academic University 
Hospital.  
 
EXPERIMENTAL ANIMALS 
In paper I ten pigs with a mean weight of 28 kg (range 24-29) were used. Papers II and III 
are based on data from ten pigs with mean weight of 35 kg (range 30-40). Eight pigs with 
mean weight of 34 kg (range 32-36) were used in paper IV. The experiments were conducted 
with the animals placed in the supine position except in paper I where they were positioned in 
the semilateral position. 
 
ANAESTHESIA AND SURGICAL PREPARATION 
Just after arrival to the laboratory, the animals were sedated via an intramuscular injection of 
0.04 mg/kg atropine (NM Pharma AB, Sweden), 6 mg/kg tiletamine-zolazepam (Zoletil, 
Vibrac Laboratories, France), and 2.2 mg/kg xylazine chloride (Rompun, Bayer AG, 
Germany). After establishing an intravenous line a bolus dose of 5µg/kg fentanyl (Fentanyl 
B. Braun, Germany) was administered. The animals were intubated via direct laryngoscopy 
in paper I and via a tracheostomy in papers II-IV.  
An intravenous infusion of ketamine 30 mg/kg/h, midazolam 0.1mg/kg/h and fentanyl 4 
µg/kg/h was administered for maintenance of anaesthesia and rocuronium 2mg/kg/h for 
muscle relaxation. Anaesthetic level was evaluated prior to administration of muscle 
relaxant by applying pain stimuli to the fore hoof with a forceps. 
Ventilation was performed in a volume-controlled mode (Servo-i; Maquet, Solna, Sweden) 
with a tidal volume of 10 mL/kg in papers I-III. In paper IV a tidal volume of 8 and 12 
mL/kg was used. FiO2 was set to 0.4 in papers I and IV while in papers II and III, a FiO2 of 
1.0 was used to calculate the true shunt fraction and to ensure animal stability during lung-
lavage. Baseline positive end-expiratory pressure (PEEP) was set to 5 cmH2O and the 
respiratory rate was adjusted to a frequency of 25 to 30 aiming at a systemic arterial partial 
pressure of carbon dioxide (paCO2) of approximately 40 mmHg.  
An intravenous infusion of Ringer’s lactate was infused at the rate of 10 mL/kg/h. If there 
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were signs of hypovolemia, i.e. significant tachycardia and/or hypotension, additional 
colloid solution (Hesra, Baxter, Chicago, IL, USA) was administered in boluses of 100-200 
mL. 
The jugular vein and femoral artery were cannulated for administration of vasoactive drugs 
and arterial pressure recordings. An 8 Fr Fogarty occlusion catheter was inserted via 
ultrasound guidance into the femoral vein for preload reduction by intermittent occlusions 
of the caval vein. In papers I and IV a 13.5 Fr catheter was inserted into the femoral artery 
for controlled bleeding. A urinary catheter was placed via a small surgical incision into the 
urinary bladder and the body temperature was maintained at 38-39° C with warming 
mattresses and blankets.  
When the preparation was finished the animals were left to recover for 30 minutes before 
BL recordings were obtained.  
The animals were anaesthetised through the whole experiment and when it was completed, 
they were sacrificed by an injection of potassium chloride. 
 
CARDIAC OUTPUT MONITORING 
The ultrasonic flow probe 
In all studies an ultrasonic flow probe (COTS) functioned as the reference method for CO and 
was placed around the pulmonary trunc via a left sided thoracotomy (T 401; Transonic 
system Inc, Ithaca NY, USA). The size of the flow probe was adjusted to the size of the 
pulmonary trunk (16, 18 or 20 mm). Before the flow probe was put in position ultrasonic gel 
was applied between the vessel and the probe. The chest was then closed and the animals 
repositioned in the supine, papers II-IV or semilateral position in paper I (Figure 4). 
Each COTS reading was based on an average of approximately ten seconds and recorded 
simultaneously with COEPBF. The inspiratory or expiratory holds within the nine or ten 
breaths cycle were randomly distributed in relation to the readings of COTS. 
 
Materials and Methods 
   17 
 
Figure 4. Via a left sided thoracotomy the pulmonary trunc was dissected. The size of the probe was selected 
by visual guidance. Ultrasonic gel was applied between the ultrasonic flow probe and the vessel. 
 
The pulmonary artery catheter 
A balloon-tipped 7.5 Fr PAC (COPAC) (Edwards Lifesciences, Irvine, CA, USA) was 
inserted via the right jugular vein into the pulmonary artery for monitoring of CO, pressure 
recordings and sampling of mixed venous blood gases. In paper I CO was determined by 
the mean of three 5 mL boluses of ice cold saline and in papers II-IV by the mean of three 
10 mL boluses of ice cold saline. Because the injections caused instability of the carbon 
dioxide signal in the measured expired gas these measurements were always performed 
after the COTS and COEPBF readings. 
Transpulmonary thermodilution 
In paper IV a 4 Fr artery catheter (PiCCO Pulsion, Munich, Germany) was inserted via 
ultrasound guidance in the contralateral femoral vein and connected to the special device for 
the transpulmonary thermodilution PICCO2 (PiCCO Pulsion, Munich, Germany). An average 
of three injections of 10 mL ice cold saline injected in the central venous catheter was used 
for calculation of CO at all interventions and at BL. The continuous pulse wave analysis was 
not used. 
 
LUNG INTERVENTIONS AND MEASUREMENTS 
Reference method for functional residual capacity 
In paper III a device for dispensing the tracer gas, sulphur hexafluoride (SF6), was connected 
to the breathing circuit and SF6 was delivered in proportion to the inspiratory flow with a 
subsequent constant concentration regardless the inspiratory flow pattern. The amount of SF6 
at the end of wash in was calculated during wash out and the functional residual capacity with 
a positive PEEP (FRCPEEP) could be estimated (78). 
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Lung-lavage 
In papers II and III lung injury (i.e. surfactant depletion) was induced by repeated lung-
lavages (approximately 30 mL/kg) with 37º C saline solution at a FiO2 of 1.0 and PEEP 5 
cmH2O. The procedure was stopped after obtaining a stable P/F ratio of  < 75.  
Calculations of shunt and dead space 
Berggren’s formula was used for estimation of shunt fraction (79). Dead space was 
assessed by the classical Bohr’s formula as described by Tusman et al. in paper II (80) and 
calculated according to Enghoff in paper III (81). 
 
THE CAPNODYNAMIC METHOD   
Effective pulmonary blood flow and ELV was calculated from a dynamic mole balance 
equation for the carbon dioxide content in the lung. Software in a modified ventilator 
(Maquet Critical Care, Solna, Sweden) induced the required changes by varying the 
ventilatory pattern in a predefined way. Data from the most recent ten or nine respiratory 
cycles are included in the on-going analysis. 
 
The ventilatory pattern 
In papers I-III the ten most recent breaths were included in the on-going analysis. Five   
subsequent respiratory cycles including a breath hold prolonging the inspiratory part of the 
cycle were followed by five normal respiratory cycles (Figure 5). 
In paper IV the ventilatory pattern was modified and the number of breaths included in one 
test cycle was reduced to nine. Three respiratory cycles with an imposed end-expiratory 
pause were followed by six normal respiratory cycles (Figure 6). 
To maintain an unaltered minute ventilation the breath rate for respiratory cycles without 
imposed pauses was increased. 
 
Figure 5. The ventilatory pattern in papers I-III, five normal cycles are followed by five respiratory cycles with 
an inspiratory hold. 
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Figure 6. The ventilatory pattern in paper IV, six normal cycles are followed by three respiratory cycles with an 
expiratory hold. 
 
The capnodynamic equation 
The capnodynamic equation (see below) describes a mole balance of carbon dioxide 
between the transport of carbon dioxide to and from the lung and the rate of change of the 
carbon dioxide content in the lung induced by the alternating ventilatory pattern. 
The left side of the equal sign expresses the difference in mean alveolar carbon dioxide 
content in the lung between two breaths (measured). Effective lung volume (calculated) 
represents the gas volume in the lung containing carbon dioxide.  
The first term to the right of the equal sign, EPBF (calculated) represents the circulatory 
supply of carbon dioxide to the lung. Δt n expresses the duration of each breathing cycle, 
which varies due to the imposed breath holds. CvCO2, venous carbon dioxide content 
(calculated) is assumed to be constant during a measurement cycle.  
The carbon dioxide content of pulmonary end-capillary blood, CcCO2, is calculated from the 
measured alveolar partial pressure, PACO2, which is assumed to correlate closely to the 
partial pressure of carbon dioxide of the pulmonary end-capillary blood. To convert the 
partial pressure of carbon dioxide to concentration the impact of the dissociation curve for 
carbon dioxide in blood described by Capek et al. was used (63). The effect on the 
dissociation curve displayed by variation in the concentration of haemoglobin is included in 
the described formula and a haemoglobin value obtained at the beginning of the experiment 
was programmed into the software (63). The last term VTCO2n displays the quantity of 
carbon dioxide exhaled by the nnt tidal volume. 
FACO2 is estimated from the midpoint value of a linear function fit to the alveolar plateau 
(phase III) of the volumetric capnogram (82). 
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ELV             Effective lung volume [L] 
EPBF Effective pulmonary blood flow [L/min] 
n  current breath  
n-1  previous breath  
FACO2 mean alveolar carbon dioxide fraction 
CvCO2 mixed venous carbon dioxide content [Lgas/Lblood] 
CcCO2n end-pulmonary capillary carbon dioxide content [Lgas/Lblood] 
VTCO2n  volume [L] of carbon dioxide eliminated by the current, nth, breath 
Δt n  current breath cycle time [min]  
 
Each breathing cycle results in a new equation. All quantities except ELV, EPBF and CvCO2 
are directly determined from measurement breath-by-breath. An overdetermined set of ten or 
nine equations solved through a least-square-error optimisation of the fit between the left-
hand-side and the right-hand-side of the equation calculates values for ELV, EPBF and 
CvCO2.  
A prerequisite for this is the assumption that ELV, EPBF and CvCO2 remain constant during 
the complete measurement cycle consisting of a set of ten or nine breaths. The method is 
continuous because the measurement cycle is constantly updated with the most recent 
equation and expelling the last. 
The measured data in the capnodynamic method are compared to an ideal one-lung 
compartment model. If the differences are too large between the optimal lung model and the 
measured data the equation cannot be solved and no values for ELV or EPBF can be 
calculated. A correction for the shunt fraction is not included.   
 
DATA SAMPLING AND RECORDING 
Pressure readings and haemodynamic signals were recorded and sampled (at 100 Hz) into a 
data acquisition system (Acknowledge, version 3.2.7, Bio Pac Systems, Santa Barbara, CA, 
US) to allow post processing of data. 
Carbon dioxide and gas flow were measured by the ordinary mainstream carbon dioxide 
and flow sensors of the Servo-i ventilator, that were connected to a lap top computer where 
all the analysis were carried out by a software written in MatlabTM (Mathworks) 
 
( ) ( )12 2 2 2 2n n n n nA A v cELV F CO F CO EPBF t C CO C CO VTCO−⋅ − = ⋅Δ ⋅ − −
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PAPER I  
In paper I we evaluated COEPBF during significant haemodynamic alterations with COTS and 
COPAC as reference methods. The performance of COPAC was also evaluated per se with COTS 
as reference method. The ventilatory pattern was based on inspiratory holds.  
Experimental protocol 
After BL measurements were recorded the following interventions were performed:  
(Figure 7) 
1) Preload reduction by partial caval occlusion reducing COTS by 50%. 
2) Afterload increase by infusion of phenylephrine increasing mean arterial pressure           
(MAP) to 150% of BL.  
3) Decreasing afterload by an infusion of nitroprusside decreasing MAP to 60% of BL. 
4) Inotropic stimulation by infusion of dobutamine increasing COTS to 200% of BL.  
5) An intravenous volume challenge of 500 mL colloid. 
6) Controlled bleeding reduced MAP to 35 mmHg.  
Each haemodynamic intervention was followed by a stabilisation period where one BL 
reading was performed. At initial BL and during all haemodynamic interventions three 
readings were obtained except during haemorrhage were two readings were performed. 
All paired CO data were recorded under haemodynamic steady state conditions as judged 
by the COTS. 
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Figure 7. A schematic description of the haemodynamic interventions in paper I. Three consecutive 
measurements by all methods were obtained at initial baseline and interventions expect during haemorrhage 
where two measurements were performed. At baseline between interventions, one measurement was obtained. 
A PEEP of 5 cm H2O was used during the whole experiment (N=10). 
 
PAPER II  
In paper II we evaluated COEPBF during significant haemodynamic and PEEP alterations with 
COTS as the reference method before and after lung-lavage. The ventilatory pattern was based 
on inspiratory holds. 
Experimental protocol 
After BL measurements were recorded the animals were randomised to start the 
haemodynamic interventions at PEEP 5 or 12 cmH2O. Then the haemodynamic situation 
was altered by: 
(Figure 8) 
1) Preload reduction by caval occlusion aiming to decrease COTS to 50% of BL.  
2) Infusion of dobutamine titrated to increase COTS to 150% of BL.   
The PEEP level was then altered and the haemodynamic interventions repeated in the same 
order.  
After lung-lavage, described above, the haemodynamic interventions were repeated first at 
PEEP 5 cmH2O and then at PEEP 12 cmH2O. 
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Between all interventions there was a recovery period at BL conditions where 
measurements were obtained. During each intervention and at BL two paired CO 
measurements were obtained in haemodynamic steady state conditions as judged by COTS.  
 
 
Figure 8. A schematic description of the protocolled interventions in paper II. After the initial baseline (BL) 
measurements, the animals were randomised to start at PEEP 5 or 12 cmH2O. At each PEEP step the same 
sequence including BL, preload reduction and inotropic stimulation was induced and two measurements were 
obtained at each intervention and BL. The red line represents lung-lavage. The protocol was then repeated after 
lavage, but not in a randomised PEEP order (N=9). 
 
PAPER III 
In paper III we assessed the stability of ELV during significant CO alterations and 
compared ELV to a reference method for FRC at different PEEP levels before and after 
lavage. The ventilatory pattern was based on inspiratory holds. 
Experimental protocol 
After BL measurements were recorded the animals were randomised to start the 
haemodynamic interventions at PEEP 5 or 12 cmH2O. Then the haemodynamic situation 
was altered by: 
(Figure 9) 
1) Preload reduction by caval occlusion aiming to a reduction of COTS to 50% of BL.  
2) Infusion of dobutamine titrated to increase COTS to 150% of BL.  
The PEEP level was then altered and the haemodynamic interventions repeated in the same 
order.  
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After lung-lavage, described above, the haemodynamic interventions were repeated first at 
PEEP 5 cmH2O and then at PEEP 12 cmH2O. Before ending the experiment the PEEP level 
was reduced to 0 where thereafter CO, ELV, and FRCPEEP were recorded (N=7).  
Effective lung volume was recorded at BL and during all interventions. Due to 
haemodynamic instability during preload reduction and inotropic stimulation the 
corresponding FRCPEEP measurements were obtained only at BL.  
 
 
Figure 9. A schematic description of the protocolled interventions in paper III. After the initial baseline 
measurements, not included in the graph, the animals were randomised to start at PEEP 5 or 12 cmH2O. Baseline 
measurements were followed by preload reduction and inotropic stimulation. The PEEP level was altered and the 
interventions repeated. After lung-lavage was performed, represented by the red line, the interventions were 
repeated but not in a randomised order. ELV (mL) values were obtained during baseline and interventions. Due to 
haemodynamic instability FRCPEEP (mL) was measured only at baseline conditions (N=7-9). 
PAPER IV 
In paper IV we evaluated COEPBF during haemodynamic and PEEP alterations as well as 
different tidal volumes with COTS as the reference method. COPAC and COTPT were also 
compared to COTS per se. The ventilatory pattern was based on expiratory holds. 
Experimental protocol 
Baseline measurements of COTS, COEPBF, COPAC and COTPT were obtained at PEEP 5 cm 
H2O and a TV of 8 mL/kg. The haemodynamic situation and ventilator settings were then 
altered by: 
(Figure 10) 
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1) PEEP 0 cmH2O and 12 cmH2O 
2) Increased tidal volume of 50% from 8 to 12 mL/kg 
3) At BL conditions preload reduction to COTS 50% of BL by caval balloon inflation. 
4) Increase of PEEP from 5 to 12 cmH2O 
5) Preload reduction of COTS 50% of BL at PEEP 12 cmH2O by caval balloon inflation. 
6) Alteration of the PEEP level from 12 to 5 cmH2O. 
7) At BL conditions increase of COTS to 150% by an infusion of dobutamine 
8) Controlled bleeding titrated to a MAP of 35 mmHg.  
All measurements were accomplished at steady state conditions as judged by COTS. During 
all interventions one measurement was obtained except at preload reduction PEEP 5 and 12 
cmH2O, inotropic stimulation and haemorrhage where two measurements were recorded. 
Between all interventions there was a recovery period at BL conditions where one 
measurement was obtained. 
 
 
Figure 10. A schematic description of the haemodynamic and ventilatory manipulations in paper IV. After    a 
stabilisation period and baseline measurements the ventilatory settings were changed by alterations of PEEP and 
tidal volume (TV). This was followed by haemodynamic alterations at two different PEEP levels. One 
measurement from each monitor was obtained at baselines and all interventions except during preload reduction, 
inotropic stimulation and haemorrhage where two measurements were obtained.  (N=8).  
 
STATISTICAL METHODS AND CALCULATIONS 
Cardiac output data were checked for normal distribution by the Kolmogorov–Smirnov test 
in paper I and D’Agostino and Pearson omnibus K2 test in papers II-IV. Wilcoxon’s 
matched-pairs signed rank test was used to calculate significant differences in paper II. A 
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one-way ANOVA for repeated measurements was used for calculation of differences in 
ELV between the corresponding PEEP levels before and after lavage in paper III. A paired 
t-test was used for calculations of p-values between ELV and FRCPEEP within each PEEP 
step. Pearson’s correlation coefficient was used to assess the correlation between absolute 
values and paired delta values. A p -value of < 0.05 was considered statistical significant. 
 
Inherent precision 
Inherent precision was defined as twice the coefficient of variation (CV). CV= SD/mean 
(83). 
In paper I the inherent precision for COEPBF and COTS were calculated across all animals by 
including three consecutive BL measurements from each CO monitor during 
haemodynamic steady state. The inherent precision of COPAC was calculated as twice the 
coefficient of error (CE) (CV/√3), of the three averaged thermodilution curves from the 
same BL period.  
In papers II and IV COEPBF data and in paper III ELV data from each tidal volume was 
collected from the sampling system, typically during 5-10 minutes, at the first BL period. 
Standard deviation of the included CO data and mean CO were calculated across all 
animals. The inherent precisions of COEPBF and ELV were recalculated at BL conditions 
after lung-lavage was performed in papers II and III. 
Agreement  
Bland Altman statistics were used for evaluation of absolute values. (84). When repeated 
measurements were obtained from the same subject an adjustment for multiple 
measurements was made (85).  
Trueness defined as the mean difference between the test and the reference method was 
described by bias (84, 86). Limits of agreement (LoA) estimate the spread of the included 
paired values and were calculated as bias ± (1.96xSD). 95% of the paired data will be 
positioned within those limits (84, 86) (Figure 11). 
The percentage error (PE), relating the spread in the sample to the mean of the reference 
method, was calculated as 1.96xSD divided by the mean of the reference method (84). A 
priori we considered a PE < 30% as an indication of the two methods being 
interchangeable and < 45% as a limit of acceptance when thermodilution was used as a 
reference method for CO (83, 87, 88). 
Confidence intervals (95%) were calculated for bias, LoA and the mean polar angle in 
papers II and IV. 
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Figure 11. An example of a Bland Altman plot (paper II) assessing the agreement for absolute values. The green 
triangles represent 36 paired values displaying the difference between the capnodynamic (COEPBF) and the 
reference method for cardiac output (COTS) plotted against the mean of the corresponding data at PEEP 5 cmH2O 
after lung-lavage. The dotted blue line represents bias (L/min), i.e. the mean difference between the two 
methods. The red dotted lines represent limits of agreement (LoA) (L/min) defining the area that includes 95% 
of all the individual bias values. The black dotted lines represent confidence intervals of bias and LoA.  
Trending ability 
The agreement for the paired delta values was evaluated by two different methodologies 
assessing the concordance rate, the four-quadrant (4Q) (89) and the polar (PP) methodology 
(77). The 4Q methodology estimates the direction of change calculating the concordance 
rate as the number of paired delta values positioned in one of the two concordant quadrants 
divided by the total number of paired delta values (89). (Figure 12)  The PP methodology 
also includes the magnitude of change in the concordance rate and calibration between 
methods by calculation of the mean polar angle (angular bias). Concordance rate was 
calculated as the number of paired delta values within the radial limits of agreement of ± 
30° divided by the total number of paired delta values (77) (Figure 13). 
Since central data points reflect random measurement errors rather than trending ability an 
exclusion zone of 10-15% was used for both methods (77, 89, 90).  
A concordance rate of < 90% was considered as poor, > 90-95% as acceptable to good for 
the 4Q methodology (89, 91). A concordance rate of  > 90% was considered acceptable for 
the PP methodology (91). An angular bias of equal or less then ±5° indicated good 
calibration of the test method in comparison with the reference method (77).  
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Figure 12. An example of a four-quadrant plot from paper I showing the trending abilities for the 
capnodynamic method (COEPBF) blue triangles and thermodilution (COPAC) green squares compared to the 
reference method for CO (COTS). Fifty-six paired delta CO values (L/min) are displayed. The correlation 
coefficients for both COEPBF and COPAC are also shown. Data points plotted in the upper right and lower left 
quadrants are considered concordant. The shadowed square in the middle marks the exclusion zone, in this 
example 15% (0.4 L/min), corresponding to small changes in CO considered to reflect random measurement 
errors rather than trending ability. 
 
 
 
Figure 13. An example of a polar plot from paper I for the capnodynamic method (COEPBF) using the 
ultrasonic flow probe COTS as reference method. The blue zone in the middle represents the exclusion zone. 
Data spread closely to the polar axis indicates good trending. Lines indicate ±30° radial limits. 
 
	  
	  
Materials and Methods 
   29 
Statistical	  computer	  programs 
All statistical calculations except for the polar plots were done in GraphPad Prism (version 
6.0 for Windows, GraphPad Software, San Diego, CA, USA). For calculation of polar 
plots, an excel sheet for conversion of Cartesian data to polar coordinates was used kindly 
provided by Professor L Critchley.  
Sigma Plot (version 12.0 for Windows, Systat software, Inc., GmbH, Germany) was used to 
construct the polar plots.  
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RESULTS 
 
All animals survived the protocolled interventions. Data from one animal were excluded 
because of problems with data acquisition in papers II and III.  
 
PAPER I 
The haemodynamic interventions resulted in marked alterations of COTS ranging from 1.2 to 
4.9 (mean 2.6) L/min (Figure 14). 
Inherent precision was calculated for all CO monitors: COTS ± 1%, COEPBF ± 2.5%, and 
COPAC ± 4.3% at BL. The inherent precision of COPAC was ± 7%. 
 
 
Figure 14. Cardiac output (L/min) obtained by the reference method for CO (COTS) black dots, the 
capnodynamic method (COEPBF) blue triangles, and the pulmonary artery catheter (COPAC) green squares at 
baseline and during haemodynamic interventions. Each haemodynamic challenge was followed by a baseline 
stabilisation period. Data are presented as mean (±SD) (N=6-10). 
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Agreement  
COEPBF and COPAC showed an overall consistency in relation to COTS in response to the 
haemodynamic interventions. COEPBF tended to overestimate CO slightly with an overall bias 
(LoA) of 0.2 (-1.0 to1.4) L/min. This result was comparable to the corresponding values for 
COPAC showing similarly good agreement with bias (LoA) of 0.3 (-1.0 to1.6) L/min. 
However, the overall percentage error was 47% for COEPBF and 49% for COPAC.  
COEPBF was also compared to COPAC, being a clinical reference method for CO. COEPBF 
showed good agreement for all interventions except during dobutamine infusion when COEPBF 
underestimated and COPAC overestimated CO as assessed by COTS. 
Trending ability 
The concordance rate, as assessed by the four-quadrant methodology was 97% and 95% for 
COEPBF and COPAC respectively. When the polar plot methodology was used, the 
corresponding values were 97% (angular bias of -5.6°) and 100% (angular bias of 0.93) for 
COEPBF and COPAC respectively.  
 
PAPER II 
The haemodynamic interventions resulted in marked alterations of COTS ranging from 0.9-8.9 
(mean 3.4) L/min (Figure 15). 
Inherent precision was calculated for COEPBF and remained ± 9% both before and after lung-
lavage. The inherent precision of COTS was previously shown to be ± 10% (92). 
Lung-lavage resulted in a significant decrease in lung function with a two-fold increase in 
shunt fraction and decreased compliance. When PEEP was increased to 12 cmH2O after lung-
lavage, the shunt fraction was reduced indicating a restored lung function. 
At each PEEP level the shunt fraction was dependent of CO regardless of the degree of lung 
injury and PEEP level. The difference between COEPBF and COTS increased with increased 
shunt flow. When shunt levels was > 20%, COEPBF underestimated COTS.  
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Figure 15. Cardiac output (L/min) displayed by the reference method for cardiac output (COTS) black dots and 
the capnodynamic method (COEPBF) blue triangles at baseline and during haemodynamic interventions at PEEP 5 
and 12 cmH2O before and after lung-lavage. Data are presented as mean (± SD). The red vertical line represents 
lung-lavage (N = 9). 
 
Agreement 
When PEEP was increased to 12 cm H2O before lung-lavage COEPBF showed a paradoxical 
increase compared to COTS bias (LoA) and PE 1.4 (-1.3 to 4.2) l/min and 90% (table). Lung-
lavage affected the performance of COEPBF resulting in decreased agreement and precision 
with bias (LoA) and PE of -0.9 (-3.6 to 1.9) 70% (Table 1). 
 
Trending ability  
The trending ability was preserved before and after lung-lavage with a concordance rate of 
94% as assessed by the four-quadrant methodology. The polar plot methodology showed a 
concordance rate of 100% and an angular bias of -4.0° at PEEP 5 cm H2O before lung-lavage. 
However, after lavage the concordance rate decreased to 89% and the angular bias was -16.4° 
indicating suboptimal calibration (Table 1). 
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Table I. Paper II, agreement between the capnodynamic method (COEPBF) and the reference method for CO (COTS) 
as assessed by the Bland Altman methodology. Bias, limits of agreement (LoA) (L/min) and percentage error (PE 
%) are displayed for the different PEEP levels before and after lung-lavage. Two different methodologies were used 
to assess the trending ability (concordance %), the four-quadrant (4Q) and the polar (PP) methodology. The mean 
polar angle indicates how well the test method is calibrated to the reference method. Eighteen paired delta values 
were included in calculation of concordance rate (N=9). 
 
PAPER III 
The haemodynamic interventions resulted in marked alterations of COTS ranging from 0.9-8.9 
(mean 3.4) L/min.  
Inherent precision for ELV was calculated both before and after lavage to ± 4.5% and ± 9.0 
respectively. The inherent precision of COTS was previously shown to be ± 10% (92) and the 
corresponding value for FRCPEEP was ± 6.0% (78). 
Lung-lavage caused a significant increase in shunt fraction and a 40% reduction of FRCPEEP 
indicating deterioration of the lung function.   
ELV was not significantly affected by CO alterations within the same PEEP level. A small 
difference between ELV and FRCPEEP was seen at PEEP 5 cmH2O before lavage and at PEEP 
12 cmH2O after lavage. (Figure 16) 
 
 PEEP 5 
(cmH2O) 
before lavage 
PEEP 12 
(cmH2O) 
before lavage 
PEEP5 
(cmH2O) 
after lavage 
PEEP 12 
(cmH2O) 
after lavage 
Bias (LoA) 
PE 
0.2 (-1.1 to 1.5) 
34% 
n=45 
1.4 (-1.3 to 4.2) 
90% 
n=36 
-0.9 (-3.6 to 1.9) 
70% 
n=36 
0.8 (-1.5 to 3.1) 
75% 
n=36 
4Q 94% 94% 94% 100% 
PP 
 
100% 
-4.0° 
89% 
3.1° 
89% 
-16.4° 
89% 
-2.5° !
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Figure 16. Upper panel shows the effective lung volume, ELV (mL) during caval occlusion and dobutamine 
infusion at different PEEP levels before and after lavage. Lower panel displays the corresponding cardiac output 
values (L/min), obtained by the reference method for CO. Data are displayed as mean (± SEM). No significant 
differences in ELV were seen within the PEEP steps using one-way ANOVA analysis. The red line represents 
lung-lavage (N=9). 
 
A high shunt fraction impaired the agreement between ELV and FRCPEEP  (Figure 17). 
 
 
Figure 17. The difference between ELV (mL) and the reference method for FRC, FRCPEEP (mL), plotted against 
shunt fraction. The deviation from zero is significant in PEEP 5 after lung-lavage (p=0.03). 
 
 
Caroline Hällsjö Sander 
 36 
Agreement  
The overall agreement was, bias (LoA) and PE, -35 (-271 to 201) mL, and 36%. When data 
were divided in two groups, before and after lavage the corresponding values was 29 (-207 to 
263) mL, 26% and -77 (-272 to 118) mL, 39%, respectively. 
Trending ability 
The ability for ELV to detect trends between PEEP steps, showed a concordance rate of 100% 
as assessed by the four-quadrant methodology. 
 
PAPER IV 
The haemodynamic interventions resulted in marked alterations of COTS ranging from 1.3 and 
8.0  (mean 3.2) L/min (Figure 18). 
Inherent precision for COEPBF was calculated to ± 14%. The inherent precision of COTS was 
preciously shown to be ± 10% (92) and ± 8% for COTPT (47). 
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Figure 18. Cardiac output (L/min) is displayed on the y-axis as measured by the reference method for CO 
(COTS), black dots and the capnodynamic method (COEPBF) blue triangles. The haemodynamic and ventilatory 
interventions are displayed on the x-axis. The corresponding PEEP values are displayed at the top of the diagram 
(cmH2O). Data are presented as mean (±SD) (N=8). 
 
Agreement  
The overall agreement for COEPBF was preserved compared to the results in paper I and the 
precision was improved with an overall PE of 36%. At high PEEP levels a decrease in 
precision was seen with a PE of 41% and wider LoA. The overall performance of COPAC was 
equal compared to our previous results in paper I.  
COTPT displayed the best precision of all methods with a PE < 30% in all intervention steps 
except during inotropic stimulation. Data for absolute values of the three different methods are 
displayed in table 2.  
Trending ability 
Sixty-two paired delta values of COEPBF and COTS were analysed by the four-quadrant and the 
polar plot methodology, concordance rate was 97% and 94% respectively (mean polar angle 
0.4°).  
The corresponding values for COPAC was 96% and 92% (mean polar angle -8.1°) and COTPT 
97% and 95% (mean polar angle 1.8°) (58 paired delta values). 
 
Table 2. Table showing results from Bland Altman analysis for the capnodynamic method (COEPBF), the pulmonary 
! COEPBF  
bias (LoA) 
PE 
COPAC  
bias (LoA) 
PE 
COTPT  
bias (LoA) 
PE 
Overall 
0.05 (-1.1-1.2) 
36% 
(n=141) 
-0.2 (-1.6-1.2) 
45% 
(n=97) 
0.5 (-0.4-1.5) 
29% 
(n=109) 
PEEP 5 
0.1 (-0.9-1.2) 
32% 
(n=70) 
-0.2 (-1.7-1.2) 
38% 
(n=48) 
0.5 (0.6-1.6) 
29% 
(n=54) 
PEEP 12 
0.2(1.0-1.4) 
41% 
(n=32) 
0.1 (-1.3-0.1) 
46% 
(n=21) 
-0.5 (-0.3-1.2) 
30% 
(n=24) 
High CO 
-0.3 (-2-1.4) 
27% 
(n=16) 
0.09 (-1.4-1.6) 
24% 
(n=7) 
-0.05 (-2.1-2) 
31% 
(n=14) 
Low CO 
-0.09 (-0.8-0.6) 
33% 
(n=46) 
-0.08 (-1.0-0.8) 
45% 
(n=21) 
0.43 (-0.2-1.1) 
28% 
(n=24) !
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artery catheter (COPAC) and the transpulmonary thermodilution (COTPT) when compared to the ultrasonic flow probe 
(COTS) (L/min). The paired measurements are separated into five subgroups; overall, including all measurements, 
the two different PEEP steps 5 and 12 cmH2O, high (inotropic stimulation) and low (preload reduction and 
haemorrhage) CO states. The bias, limits of agreement (LoA) (L/min) and percentage error (PE %) for each method 
are displayed in the corresponding column. n=numbers of paired CO values included in the calculation (N=8). 
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DISCUSSION 
 
In this thesis we have evaluated and further developed a capnodynamic method for 
assessment of EPBF and ELV. We used significant haemodynamic and ventilatory alterations 
in order to scrutinise the method during extreme conditions. Moreover, we used modern 
statistical methods. We have found that the overall agreement and trending ability were 
comparable to the invasive clinical reference method for CO and that ELV remained stable 
during haemodynamic alterations.  
However, lung-lavage with subsequent surfactant depletion impaired the performance of 
COEPBF especially when the shunt fraction was over 20% leading to an underestimation of 
CO. The paradoxical increase of COEPBF when PEEP was increased to 12 cmH2O in paper II 
was not seen when the COEPBF was evaluated with the expiratory-based ventilation pattern. 
Furthermore, the overall precision was improved when using the modified ventilator setting.  
 
CHOICE OF ANIMAL MODEL AND REFERENCE METHODS 
Pigs are in the physiological sense rather similar to humans even though there are apparent 
differences (93, 94). Because of the requirement for extensive surgical procedures, 
instrumentation and frequent blood sampling, the size of the animals also had to be suitable. 
In paper I the animals were smaller compared to the animals in the following papers. This 
made the preparation more difficult and the lower BL CO could have negatively affected 
some of the statistical calculations, such as PE (83). Since the method was evaluated for 
potential use in adults and the experimental model required significant manipulations larger 
sized pigs were selected for papers II-IV. 
Our decision to use multiple lung-lavages to induce surfactant depletion may be questioned 
since this model induces a non-sustainable decrease in lung function more than a persistent 
lung-injury (95). However, our intention was not to study lung injury per se but to study 
how the performance of COEPBF was affected by this temporary disturbance in lung function 
with subsequent increased shunt fractions and low P/F ratio. Furthermore, the lavage model 
is reproducible and easy to perform. It is also well tolerated by the animals since it is 
performed in a stepwise way and could be adjusted to the individual response. 
Limitations also include the choice of reference methods. COTS measures flow in the 
pulmonary trunk with high agreement and precision (75, 76). COEPBF on the other hand 
estimates non-shunted blood flow. In summary, the test and the reference method do not 
measure the exact same entity. However, since there is a lack of a reference method for 
EPBF, we decided to use COTS considering it is the gold standard for flow measurements in 
animal research. Furthermore, EBPF could be assumed to correlate closely to CO when shunt 
fractions are low.  
Also the relationship between ELV and FRCPEEP is complicated since they measure slightly 
different lung volumes. FRCPEEP measures an anatomical lung volume where the tracer gas 
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spreads in all open parts of the alveoli whereas ELV corresponds to the functional lung 
volume participating in carbon dioxide exchange. The SF6 has been found to correlate with 
Helium wash in/wash out, a reference method for FRC (78). Furthermore, the measurements 
are reproducible and easy to obtain and the method could be used when PEEP is applied.  
 
INHERENT PRECISION 
We calculated the inherent precision of COEPBF in all papers. In paper I the precision was 
high, a finding that was not repeated in the following papers. A difference in the 
methodology when data were sampled could have contributed to this finding. In paper I we 
included three BL values for each monitor. In papers II-IV we improved our methodology 
and included longer BL periods collected from the data sampling system and analysed the 
SD and mean across all included values for calculation of precision. This approach when 
multiple values were included in the analysis resulted in lower inherent precision in all 
papers. However, the inherent precision was still under 20%. 
 
TRENDING ABILITY 
Interest in functional haemodynamic monitoring is increasing and the advantages of 
monitoring CO trends have been highlighted in the literature (2, 17, 83). Several 
publications argue that the ability to rapidly detect trends is more important than the 
agreement of absolute values when goal-directed protocols are used (72, 96). 
When trending ability was assessed by the traditional 4Q methodology, concordance rates 
were acceptable or good. However, when the modern PP methodology also assessing the 
magnitude of the changes was used, concordance rate decreased during high PEEP levels 
and after surfactant depletion. 
In multiple studies COTS displays an inherent precision below 20% (75, 76). Critchley et al. 
suggests that the exclusion zones should be narrower when the inherent precision of the 
reference method is lower than 20% (90). In paper I we used an exclusion zone of 15%. 
Considering the low precision of COTS this limit could be considered too generous. In 
papers II-IV we adjusted the exclusion zones to 10%. 
 
AGREEMENT AND PRECISION 
COEPBF performed equally when compared to the clinical reference method COPAC regarding 
overall agreement. When compared to the more precise invasive method, COTS, bias was 
considered low in all comparisons except in paper II at high PEEP levels and after surfactant 
depletion.  
A definition of an acceptable limit for bias is lacking in the literature. It is therefore left to the 
authors to decide what is acceptable in the clinical setting (17). We considered a difference 
between the test and reference methods of ± 0.5 L/min as good. This limit is based on our 
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experience as clinicians working with adult patients in the perioperative and intensive care 
settings where a difference of ± 0.5 L/min, in most clinical situations, would not alter the 
management of the patient. In adult patients this difference is relatively small compared to 
BL CO but has to be reconsidered if applied in a paediatric population. However, a consistent 
positive or negative bias represents a systematic measurement error and a solution should be 
sought to further improve trueness (86).  
Percentage error is defined as the standard deviation divided by the mean of the 
corresponding values of the reference method. This entity gives additional information by 
relating the spread of data to the magnitude of the measured entity. If the standard deviation 
is constant, PE could be acceptable when evaluated in adults, but unacceptably high in a 
neonatal population. In paper I PE was > 45% for COEPBF and COPAC demonstrating that the 
spread of data in relation to the mean COTS was higher than both of the recommended limits 
of ± 30% and ± 45% (87, 88).  
The article arguing for a PE of less than ± 30%, thus indicating that the reference method 
could be replaced by the test method, was written in 1999 by Critchley et al. (88). The ± 
30% limit was derived from an assumed inherent precision of ± 20% for the clinical 
reference method i.e. thermodilution (PAC). The combination of an inherent precision of ± 
20% for both the reference and test methods, results in a total error of ± 28.3%, which is 
commonly rounded up to ± 30% (83).  However, when the inherent precision of the PAC has 
been measured in different experimental settings a larger variation has been display (97, 98). 
For example the number of bolus injections used to calculate CO alters the inherent precision 
of the PAC, 22% for a single reading and 13% when performed in triplicate (24). 
Furthermore, the haemodynamic alterations per se might influence PE. Significant 
haemodynamic alterations especially in high CO states might cause a larger spread of the 
measured data and a higher PE compared to during stable BL conditions (87, 90). 
In a more recent publication by Peyton et al. evaluating CO monitors considered non-
invasive, none of the included devices displayed a PE of < 30%, in fact the PE was around 
45% for the majority of included methods (87). Based on these results the upper limit for an 
acceptable PE has been questioned and ± 45% has been suggested as a more realistic limit 
when thermodilution is used as reference method (87). 
During comparable conditions PE decreased from 47% in paper I, to 34% in paper II at 
PEEP 5 cmH2O before lavage. The size of the corresponding values for mean COTS could 
contribute to this finding. In paper I smaller animals with a lower CO were used compared 
to the larger sized animals with a higher mean CO in paper II. In all our papers we have 
included haemodynamic challenges and this has to be taken into account when interpreting 
the displayed PE.  
 
THE EFFECT OF LUNG-LAVAGE ON AGREEMENT AND PRECISION 
The agreement of COEPBF was negatively affected by surfactant depletion with high PE, wide 
LoA and impaired trueness. This finding is consistent with the fact that only the part of the 
pulmonary blood flow participating in gas exchange can be detected by a capnodynamic 
Caroline Hällsjö Sander 
 42 
method. The impaired agreement was especially prominent when the shunt fraction was > 
20%. Due to the correlation between CO and shunt fraction, this finding was more 
pronounced during inotropic stimulation. The lower shunt fractions seen during preload 
reduction with subsequent lower CO displayed a better agreement. 
When the direction of change of the paired delta values were analysed, trending ability was 
mostly preserved in spite of surfactant depletion. However, when the same paired delta values 
were analysed including the magnitude of change and the calibration of the test method, the 
concordance rate was decreased and the mean polar angle was high, indicating suboptimal 
calibration of COEPBF. 
The underestimation of CO by COEPBF after surfactant depletion with subsequent increased 
shunt fractions is consistent with the fact that the method in the present form does not include 
a correction factor for shunt flow. 
 
EFFECTIVE LUNG VOLUME 
Since EPBF is included in the capnodynamic equation it could be presumed that significant 
changes in CO will affect the stability of ELV. Brewer et al. have also previously highlighted 
this although no data were presented (99).  However, in in our study, ELV remained stable 
despite significant haemodynamic alterations within each PEEP level.  
A small difference between methods was detected when PEEP was adjusted to 5 cmH2O 
before surfactant depletion and at 12 cmH2O after surfactant depletion. Surfactant depletion 
decreased the numerical values of both ELV and FRCPEEP indicating a decreased lung 
function. Furthermore, the difference between ELV and the reference method increased with 
higher shunt fractions and was statistically significant at PEEP 5 cmH2O after surfactant 
depletion. This presumably reflects that ELV estimates a functional lung volume dependent 
on the matching of ventilation and perfusion. In contrast, FRCPEEP measures a static lung 
volume that reflects the volume in the lung into which the tracer gas disperses. However, the 
difference was small and the correlation was high suggesting that ELV could be used as a 
proxy for FRC during alterations of CO and lung mechanics (Figure19). 
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Figure 19. Functional residual capacity with a PEEP applied (FRCPEEP) (mL) obtained by the SF6 technique 
and the effective lung volume (ELV) (mL) at different PEEP levels before and after lung injury was induced 
by multiple lavages (red line). There were significant differences between the volumes measured by the two 
methods within the PEEP steps in PEEP 5 cmH2O before lavage  (p=0.02) and PEEP 12 cmH2O after lavage 
(p=0.03) using a paired t-test. Data are presented as mean (± SEM) (N=9). 
 
PARADOXICAL INCREASE IN COEPBF AT HIGH PEEP 
The unexpected paradoxical rise in COEPBF when PEEP was increased from 5 to 12 cmH2O 
required further analysis. The mathematical formula is complex and includes several 
assumptions. When analysed in combination with the ventilation pattern based on 
inspiratory holds affecting the pulmonary blood flow, data simulation suggested that this 
overestimation of EPBF was enhanced by the inspiratory holds (unpublished data).  
This finding is in line with previously described potential sources of error in rebreathing 
methods since alterations of the pulmonary blood flow per se may increase the differences 
between pACO2 and end-capillary carbon dioxide (100). A ventilation pattern based on 
inspiratory holds may enhance the variation of intra pulmonary pressures especially at high 
PEEP levels. A pattern based on expiratory holds could be assumed to influence these 
pressures to a lesser extent. Additionally, a ventilation pattern with cyclically reoccurring 
inspiratory holds also affects the systemic circulation, especially in hypovolemic states, an 
unfavourable attribute in the perioperative setting.  
In paper IV we evaluated COEPBF with a redesigned ventilation pattern based on expiratory 
holds during haemodynamic and lung mechanic alterations. No paradoxical increase in 
EPBF was detected and the agreement, precision and trending ability was preserved or 
improved.  
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THE LENGTH OF A MEASUREMENT CYCLE AND RECIRCULATION OF 
CARBON DIOXIDE 
The storage capacity of carbon dioxide is large compared to production in the tissues and 
extraction from the lungs. Therefore the mixed venous content of carbon dioxide could be 
assumed to be unchanged or at least vary very slowly (101).  
As previously shown in computer-based studies, the cycle time when the measurement is 
performed in relation to the size of EPBF is important for the performance of the method 
(102). In our studies the corresponding time described in the data simulation studies is equal 
to the length of one measurement cycle (9 or 10 breathing cycles). Results from a computer 
study based on a mathematical model shows that if EPBF is high the cycle time is better kept 
relatively short, and when EPBF is low a short cycle time may be inadequate. It could be 
concluded that the rebreathing cycle has to be short enough to avoid recirculation preserving 
the carbon dioxide content in the mixed venous blood at a constant level but long enough to 
assure adequate equilibration between end-capillary carbon dioxide and pACO2 (62, 102). 
This is important since a prerequisite for the capnodynamic equation is unaltered 
concentration of carbon dioxide in mixed venous blood just before and during the rebreathing 
period for each measurement cycle. In our studies this time frame corresponds to the 
measurement cycle.  
Even though no recirculation is present it seems like carbon dioxide rebreathing techniques 
even out EPBF and results in underestimation of EPBF when CO is high, as during inotropic 
stimulation, and overestimation of EPBF when CO is low (102).  
These findings are consistent with our results from paper I and at PEEP 5 cmH2O before 
surfactant depletion in paper II. Especially during inotropic stimulation in paper I where 
COEPBF underestimates CO and even shows a negative trend when the three subsequent 
measures are compared. In low CO states, as during caval occlusion and haemorrhage, 
COEPBF overestimates CO slightly. Our results from paper II showed that the shunt fraction 
varies with CO. This finding contributes to the underestimation of CO during haemodynamic 
interventions, as the capnodynamic method does not include shunt flow. 
 
ESTIMATION OF THE END-CAPILLARY CONCENTRATION OF CARBON 
DIOXIDE 
 
A differentiated Fick’s equation includes an approximation of the end-capillary 
concentration of carbon dioxide from the actually measured concentration in the alveoli. A 
coefficient, described in the introduction, for carbon dioxide is added into the equation to 
convert the partial pressure of carbon dioxide to a concentration. In our studies an approach 
to this suggested by Capek and Roy was used (63). All approximations could involve 
potential sources of error. Alternatives approaches for conversion of partial pressure of 
carbon dioxide to concentration have been described, for example by Peyton et al. in 2001 
(103).  Optimisation of the approach to convert the solubility coefficient could provide an 
option to improve trueness. 
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CARDIAC OUTPUT MONITORING  
We have high expectations of the ideal CO monitor; it should be non-invasive and safe, 
reliable with good agreement and trending abilities. Furthermore, it should be robust, 
continuous and easy to use with a short response time as well as hygienic and non-expensive. 
Unfortunately, no CO monitor has all the described qualities, in contrast it seems like they all 
have drawbacks (3, 25, 37, 38, 48, 51-53, 69, 104, 105). The non-invasive, easy to use CO 
monitors are unreliable when the circulation is unstable and the most accurate are invasive, 
potentially harmful and could be considered complicated to use (25, 53).  
When assessing a CO monitor multiple factors have to be considered. Not just the precision 
of the method per se but also the precision and performance of the reference method. 
Percentage error and LoA could be expected to improve in an experimental setting with a 
stable haemodynamic situation (87). This described complexity may contribute to the 
diverging results from the numerous studies comparing two or more CO monitors.  
In our studies the haemodynamic alterations were severe in order to evaluate the method in a 
way that is not possible in human studies. In the perioperative setting, haemodynamic shifts 
can be pronounced and rapid as in profuse haemorrhage with subsequent transfusion 
therapy. Consequently, the trending ability and response time are important properties of a 
feasible perioperative CO monitor. In paper I we have shown that COEPBF has a prerequisite 
for a fast response time. Data were collected from the sampling system from one animal 
during preload reduction and the response time in this example was 30 seconds.  
A common situation in the perioperative setting is isolated haemodynamic instability 
without prominent lung pathology. Considering COEPBF shows similar performance to the 
clinical reference method for CO this method could be considered an alternative for CO 
monitoring in patients with isolated haemodynamic instability without significant lung 
pathology. The trending ability was also high when evaluated with the breathing pattern 
based on expiratory holds.  
The choice of CO monitor should always be individualised and adjusted to the patient. The 
risk/benefit profile of available monitors should be weighed against the condition of the 
patient and the risk of complications. When the haemodynamic situation is severely impaired 
the requirement for agreement, precision and trending ability increases and a more invasive 
approach should be considered. The most invasive monitors with the opportunity for additive 
information, such as pulmonary vascular pressures and mixed venous saturation should be 
used for the most complex cases where a higher risk of the monitor per se could be justified 
by the benefit of monitoring and subsequent CO optimisation.  
In summary, COEPBF showed reliable trending abilities and good agreement when evaluated 
with a modified ventilator pattern based on expiratory holds. That COEPBF was affected by 
lung-lavage when shunt fraction increased was an expected finding since there is no 
correction for shunt fraction. Furthermore, COEPBF could be considered non-invasive in 
mechanically ventilated patients, and continuous with a prerequisite for a short response time.  
The capnodynamic equation estimates ELV, a lung volume factor that correlates to FRC (70, 
106). A monitor combining assessment of EPBF and ELV could provide an interesting 
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possibility for optimisation of both CO and ventilator settings. Last but not least, the system 
seems to be safe to use in most patients (66).  
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CLINICAL IMPLICATIONS AND FUTURE PERSPECTIVES 
 
Further evaluation of the modified ventilation pattern based on expiratory holds should be 
done after lung-lavage. The shunt fraction is not detected by a capnodynamic method 
regardless of ventilation pattern. Integration of a correction factor for shunt flow could 
improve agreement between COEPBF and CO.   
The novel expiratory-based ventilation pattern should be evaluated in patients anaesthetised 
for high-risk surgery. Alterations of the concentration of carbon dioxide could be assumed to 
affect the performance of the method. Therefore, COEPBF should be evaluated during surgery 
when perturbations of the carbon dioxide concentration are common. This might occur after 
an ischemic period during vascular surgery or in the trauma patient after the tourniquet has 
been released. Another interesting field for clinical evaluation is during laparoscopic surgery. 
It is mandatory to inflate carbon dioxide into the abdomen to facilitate the surgeon’s view. 
Since carbon dioxide equilibrates quickly with the tissue and blood this procedure might 
affect the performance of COEPBF. 
The performance of COEPBF was evaluated when dead space was increased via a higher PEEP 
level. The paradoxical increase in COEPBF was not repeated when the modified expiratory 
breathing pattern was evaluated. However, alterations in the I:E ratio is likely to affect the 
pulmonary blood flow per se. Considering emphysema and hyperactive airways are common 
clinical pathologies animal studies are warranted.  
Since the capnodynamic equation incorporates an assumption that the venous content of 
carbon dioxide is constant during a measurement cycle this should be validated. Collecting 
multiple mixed venous blood gases during a measurement cycle and comparing the carbon 
dioxide concentrations would be easy and could strengthen the evaluation of the method  
There is a lack of a feasible monitor measuring both lung ventilation and perfusion. In paper 
III ELV correlated to the reference method for FRC and showed good trending abilities. 
Furthermore, ELV was found to be stable during CO alterations. Based on these results the 
entity ELV should be evaluated in anaesthetised mechanically ventilated patients.  
A monitor of EPBF and ELV could provide an interesting option for optimisation of both 
entities. This has to be studied in relation to different breathing pattern.  
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CONCLUSIONS 
 
 
In summary, we have evaluated COEPBF and ELV in a porcine model during haemodynamic 
and ventilator alterations before and after surfactant depletion. 
 
The COEPBF method, based on inspiratory holds, showed good agreement and trending 
capability with high concordance rates and an acceptable mean angular bias when compared 
to the ultrasonic reference method and the COPAC. The overall agreement decreased slightly 
when COPAC was used as reference method whereas the trending ability was preserved. 
 
The COEPBF method, ventilation pattern based on inspiratory holds, displayed a paradoxical 
rise compared to the ultrasonic method when PEEP was increased. 
 
Lung-lavage induced significant lung injury and impaired agreement and precision of the 
COEPBF method. A significant correlation was found between impaired trueness and increased 
shunt fractions. Trending ability was largely preserved when concordance rate was assessed 
by the four-quadrant methodology. However, when assessed by the polar plot methodology 
the concordance rate decreased and the mean polar angle was wide indicating suboptimal 
calibration.  
 
ELV was stable during CO manipulation and showed good accuracy, precision and trending 
capability when compared to the reference method at baseline conditions. Lung-lavage 
impaired agreement and precision whereas trending ability was preserved.  
 
The COEPBF method, based on expiratory holds, showed an agreement and trending capability 
comparable with the ventilation pattern based on inspiratory holds. The precision as assessed 
by percentage error was improved and no paradoxical rise was detected when PEEP was 
increased.  
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